Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Da Young Lee, Jung Nyeo Chun, Minsoo Cho, Insuk So & Ju-Hong Jeon. (2023) Emerging role of E2F8 in human cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1869:6, pages 166745.
Crossref
Crossref
Nicholas J. LyonsRabina GiriJakob BegunDavid Clark, David ProudYaowu HeJohn D. Hooper & Thomas Kryza. (2023) Reactive Oxygen Species as Mediators of Disease Progression and Therapeutic Response in Colorectal Cancer. Antioxidants & Redox Signaling 39:1-3, pages 186-205.
Crossref
Crossref
Julia Pospieszna, Hanna Dams-Kozlowska, Wachirawit Udomsak, Marek Murias & Malgorzata Kucinska. (2023) Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets. International Journal of Molecular Sciences 24:13, pages 10910.
Crossref
Crossref
Vinutna Ganduri, Kruthiga Rajasekaran, Shrimahitha Duraiyarasan, Mayowa A Adefuye & Nisha Manjunatha. (2022) Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors. Cureus.
Crossref
Crossref
Xiaobo Nie, Huiyang Liu, Wenling Ye, Xiaoyun Wei, Lili Fan, Han Ma, Lanqing Li, Wanting Xue, Wenting Qi, Yan‐Dong Wang & Wei‐Dong Chen. (2022) LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer. Journal of Cellular and Molecular Medicine 26:4, pages 1095-1112.
Crossref
Crossref
Kyung-Ho Jung, Jin Hee Lee, Mina Kim, Eun Ji Lee, Young Seok Cho & Kyung-Han Lee. (2022) Celecoxib-Induced Modulation of Colon Cancer CD133 Expression Occurs through AKT Inhibition and Is Monitored by 89Zr Immuno-PET. Molecular Imaging 2022, pages 1-12.
Crossref
Crossref
Fanyuan Yu, Changhao Yu, Feifei Li, Yanqin Zuo, Yitian Wang, Lin Yao, Chenzhou Wu, Chenglin Wang & Ling Ye. (2021) Wnt/β-catenin signaling in cancers and targeted therapies. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Igor Bryukhovetskiy, Aleksandra Kosianova, Sergeis Zaitsev, Oleg Pak, Aruna Sharma & Hari Shanker Sharma. 2021. Nanomedicine and Neuroprotection in Brain Diseases. Nanomedicine and Neuroprotection in Brain Diseases
99
118
.
Ya Zhang & Xin Wang. (2020) Targeting the Wnt/β-catenin signaling pathway in cancer. Journal of Hematology & Oncology 13:1.
Crossref
Crossref
Meiling Ji, Li Ren, Yang Lv, Xinyuan Lao, Qingyang Feng, Wentao Tang, Aobo Zhuang, Tianyu Liu, Peng Zheng & Jianmin Xu. (2020) Small Nuclear Ribonucleoprotein Polypeptide N Accelerates Malignant Progression and Poor Prognosis in Colorectal Cancer Transcriptionally Regulated by E2F8. Frontiers in Oncology 10.
Crossref
Crossref
Bin Wen, Ying-Ting Wei, Lan-Lan Mu, Guo-Rong Wen & Kui Zhao. (2020) The molecular mechanisms of celecoxib in tumor development. Medicine 99:40, pages e22544.
Crossref
Crossref
Mohammadhossein Hassanshahi, Paul H Anderson, Cyan L Sylvester & Andrea M Stringer. (2019) Current evidence for vitamin D in intestinal function and disease. Experimental Biology and Medicine 244:12, pages 1040-1052.
Crossref
Crossref
Daniela Rodrigues, Terezinha Souza, Danyel G.J. Jennen, Lieve Lemmens, Jos C.S. Kleinjans & Theo M. de Kok. (2019) Drug-induced gene expression profile changes in relation to intestinal toxicity: State-of-the-art and new approaches. Cancer Treatment Reviews 77, pages 57-66.
Crossref
Crossref
Lei Luo, Ye Liang, Xuemei Ding, Xiaocheng Ma, Guiming Zhang & Lijiang Sun. (2019) Significance of cyclooxygenase‑2, prostaglandin E2 and CD133 levels in sunitinib‑resistant renal cell carcinoma. Oncology Letters.
Crossref
Crossref
Geou-Yarh Liou. (2019) CD133 as a regulator of cancer metastasis through the cancer stem cells. The International Journal of Biochemistry & Cell Biology 106, pages 1-7.
Crossref
Crossref
Mariel E Toledo-Guzmán, Gabriele D Bigoni-Ordóñez, Miguel Ibáñez Hernández & Elizabeth Ortiz-Sánchez. (2018) Cancer stem cell impact on clinical oncology. World Journal of Stem Cells 10:12, pages 183-195.
Crossref
Crossref
Hiroki Okumura, Anna Nakanishi, Tadahiro Hashita, Takahiro Iwao & Tamihide Matsunaga. (2018) Effect of Celecoxib on Differentiation of Human Induced Pluripotent Stem Cells into Hepatocytes Involves STAT5 Activation. Drug Metabolism and Disposition 46:11, pages 1519-1527.
Crossref
Crossref
Dali Tong, Qiuli Liu, Lin-ang Wang, Qiubo Xie, Jian Pang, Yiqiang Huang, Luofu Wang, Gaolei Liu, Dianzheng Zhang, Weihua Lan & Jun Jiang. (2018) The roles of the COX2/PGE2/EP axis in therapeutic resistance. Cancer and Metastasis Reviews 37:2-3, pages 355-368.
Crossref
Crossref
Bo-Wen Dong, Guang-Ming Qin, Yan Luo & Jian-Shan Mao. (2016) Metabolic enzymes: key modulators of functionality in cancer stem-like cells. Oncotarget 8:8, pages 14251-14267.
Crossref
Crossref
Chris Planque, Fatemeh Rajabi, Fanny Grillet, Pascal Finetti, François Bertucci, Meritxell Gironella, Juan José Lozano, Bertrand Beucher, Julie Giraud, Véronique Garambois, Charles Vincent, Daniel Brown, Ludovic Caillo, Jovana Kantar, André Pelegrin, Michel Prudhomme, Jérémie Ripoche, Jean François Bourgaux, Christophe Ginestier, Antoni Castells, Frédéric Hollande, Julie Pannequin & Jean Marc Pascussi. (2016) Pregnane X-receptor promotes stem cell-mediated colon cancer relapse. Oncotarget 7:35, pages 56558-56573.
Crossref
Crossref
Kamal Ahmed, Holly Shaw, Alexey Koval & Vladimir Katanaev. (2016) A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers. Cancers 8:7, pages 66.
Crossref
Crossref
ZEWEI ZHANG, HAITAO CHEN, CHAO XU, LU SONG, LULU HUANG, YUEBIAO LAI, YUQI WANG, HANLU CHEN, DANLIN GU, LILI REN & QINGHUA YAO. (2016) Curcumin inhibits tumor epithelial-mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells. Oncology Reports 35:5, pages 2615-2623.
Crossref
Crossref
Jihe Zhao. (2016) Cancer stem cells and chemoresistance: The smartest survives the raid. Pharmacology & Therapeutics 160, pages 145-158.
Crossref
Crossref
Lisa Y. Pang, Emma A. Hurst & David J. Argyle. (2016) Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy. Stem Cells International 2016, pages 1-11.
Crossref
Crossref
Yiyao Zhang, Li Liu, Pei Fan, Nathalie Bauer, Jury Gladkich, Eduard Ryschich, Alexandr V. Bazhin, Nathalia A. Giese, Oliver Strobel, Thilo Hackert, Ulf Hinz, Wolfgang Gross, Franco Fortunato & Ingrid Herr. (2015) Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. Oncotarget 6:12, pages 9999-10015.
Crossref
Crossref
Phuong N. Le, Jessica D. McDermott & Antonio Jimeno. (2015) Targeting the Wnt pathway in human cancers: Therapeutic targeting with a focus on OMP-54F28. Pharmacology & Therapeutics 146, pages 1-11.
Crossref
Crossref
Lisa Y Pang, Sally A Argyle, Ayako Kamida, Katherine O’Neill Morrison & David J Argyle. (2014) The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. BMC Veterinary Research 10:1.
Crossref
Crossref
Panagiota A. Sotiropoulou, Michael S. Christodoulou, Alessandra Silvani, Christel Herold-Mende & Daniele Passarella. (2014) Chemical approaches to targeting drug resistance in cancer stem cells. Drug Discovery Today 19:10, pages 1547-1562.
Crossref
Crossref
K. Pavlov, C. Meijer, A. van den Berg, F.T.M. Peters, F.A.E. Kruyt & J.H. Kleibeuker. (2014) Embryological signaling pathways in Barrett's metaplasia development and malignant transformation; mechanisms and therapeutic opportunities. Critical Reviews in Oncology/Hematology 92:1, pages 25-37.
Crossref
Crossref
Ahmet Altun, Nergiz Hacer Turgut & Tijen Temiz Kaya. (2014) Anticancer Effect of COX-2 Inhibitor DuP-697 Alone and in Combination with Tyrosine Kinase Inhibitor (E7080) on Colon Cancer Cell Lines. Asian Pacific Journal of Cancer Prevention 15:7, pages 3113-3121.
Crossref
Crossref
DEBAO LOU, LINA ZHU, HUAWEI DING, HAI-YAN DAI & GANG-MING ZOU. (2014) Aberrant expression of redox protein Ape1 in colon cancer stem cells. Oncology Letters 7:4, pages 1078-1082.
Crossref
Crossref
Tian-Huei Chu, Hoi-Hung Chan, Hsiao-Mei Kuo, Li-Fen Liu, Tsung-Hui Hu, Cheuk-Kwan Sun, Mei-Lang Kung, Shih-Wei Lin, E-Ming Wang, Yi-Ling Ma, Kwan-Hung Cheng, Kwok Hung Lai, Zhi-Hong Wen, Ping-I Hsu & Ming-Hong Tai. (2013) Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. Oncotarget 5:6, pages 1475-1490.
Crossref
Crossref